Please use a PC Browser to access Register-Tadawul
ACM Research (ACMR) Faces Softer Earnings Expectations Is Its Semiconductor Tool Margins Story Intact?
ACM Research, Inc. Class A ACMR | 55.79 | +3.41% |
- In recent weeks, ACM Research, Inc. (ACMR) has outperformed the broader market and attracted heightened attention ahead of its January 22, 2026 earnings release, with analysts expecting softer earnings but higher revenue and maintaining a Zacks Rank #3 (Hold).
- This renewed focus comes as the company’s semiconductor wet processing and wafer cleaning tools underpin analyst expectations for continued revenue expansion and stable margins despite mixed estimate revisions.
- We’ll now examine how this recent earnings anticipation and reaffirmed analyst stance may influence ACM Research’s existing investment narrative.
AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
ACM Research Investment Narrative Recap
To own ACM Research, you need to believe its wet processing and wafer cleaning tools will keep winning slots at advanced fabs while it manages heavy China exposure and export control risk. The latest share price surge and pre earnings optimism do not materially change that near term catalyst, nor do they lessen the ongoing risk from tighter trade rules or any slowdown in China focused wafer fab equipment spending.
Against this backdrop, the company’s November 5, 2025 update confirming 2025 revenue guidance of US$875 million to US$925 million, despite trade policy and supply chain constraints, looks most relevant, as it frames how much current expectations already factor in export related uncertainty around the upcoming earnings print.
Yet beneath the strong share price run, investors still need to consider the concentrated exposure to China’s semiconductor demand and what happens if that market...
ACM Research's narrative projects $1.4 billion revenue and $189.6 million earnings by 2028. This requires 19.1% yearly revenue growth and about a $77.5 million earnings increase from $112.1 million today.
Uncover how ACM Research's forecasts yield a $41.64 fair value, a 22% downside to its current price.
Exploring Other Perspectives
Four members of the Simply Wall St Community value ACM Research between US$36.18 and US$47.46 per share, underscoring how far opinions can spread. You may want to compare those views with the key risk that ACM’s growth is tightly tied to China’s wafer fab equipment market and consider what that could mean for future performance.
Explore 4 other fair value estimates on ACM Research - why the stock might be worth 32% less than the current price!
Build Your Own ACM Research Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your ACM Research research is our analysis highlighting 4 key rewards that could impact your investment decision.
- Our free ACM Research research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate ACM Research's overall financial health at a glance.
Looking For Alternative Opportunities?
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
- Uncover the next big thing with financially sound penny stocks that balance risk and reward.
- The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
- These 18 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.


